Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Toumi

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
Annales Pharmaceutiques Francaises|October 1, 2013
[Innovative medicines and market access agreements]M Toumi, J Zard, R Duvillard, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
A pharmacoeconomic evaluation of zuclopenthixol compared with haloperidol and risperidone in the treatment of schizophreniaK Hansen, C François, M Toumi, et al.
Therapie|July 1, 1991
[Quantitative value of the diagnostic test for a respiratory allergy: phadiatop]C Charron, M Toumi, G Jadot, et al.
Journal of Medical Economics|April 20, 2013
Assessing the economic impact of Rx-to-OTC switches: systematic review and guidelines for future developmentJ Cohen, A Millier, S Karray, et al.
Community Mental Health Journal|April 4, 2014
Evaluation of different approaches for confounding in nonrandomised observational data: a case-study of antipsychotics treatmentE Sarlon, A Millier, S Aballéa, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Drug Repurposing as An Efficient Strategy In Drug Development - Example Of Cns AreaM Toumi, S Murteira, A Caban, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Conflict Of Interest in HTA Recommendations and Case Law In FranceS Frybourg, A Kornfeld, J Brunet, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Why it is Difficult for European to Understand the Chinese Market Access Process?E Clay, J Yan, C Chen, et al.
Therapie|November 1, 1990
[Glutathione peroxidase deficiency in patients in chronic coma treated by prolonged enteral alimentation]G Jadot, A Courtière, M Toumi, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 2, 2010
Increasing escitalopram dose is associated with fewer discontinuations than switch or combination approaches in patients initially on escitalopram 10 mgT Sanglier, D Milea, D Saragoussi, et al.
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Annales Pharmaceutiques Francaises|October 1, 2013
[Innovative medicines and market access agreements]M Toumi, J Zard, R Duvillard, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
A pharmacoeconomic evaluation of zuclopenthixol compared with haloperidol and risperidone in the treatment of schizophreniaK Hansen, C François, M Toumi, et al.
Therapie|July 1, 1991
[Quantitative value of the diagnostic test for a respiratory allergy: phadiatop]C Charron, M Toumi, G Jadot, et al.
Journal of Medical Economics|April 20, 2013
Assessing the economic impact of Rx-to-OTC switches: systematic review and guidelines for future developmentJ Cohen, A Millier, S Karray, et al.
Community Mental Health Journal|April 4, 2014
Evaluation of different approaches for confounding in nonrandomised observational data: a case-study of antipsychotics treatmentE Sarlon, A Millier, S Aballéa, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Drug Repurposing as An Efficient Strategy In Drug Development - Example Of Cns AreaM Toumi, S Murteira, A Caban, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Conflict Of Interest in HTA Recommendations and Case Law In FranceS Frybourg, A Kornfeld, J Brunet, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Why it is Difficult for European to Understand the Chinese Market Access Process?E Clay, J Yan, C Chen, et al.
Therapie|November 1, 1990
[Glutathione peroxidase deficiency in patients in chronic coma treated by prolonged enteral alimentation]G Jadot, A Courtière, M Toumi, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 2, 2010
Increasing escitalopram dose is associated with fewer discontinuations than switch or combination approaches in patients initially on escitalopram 10 mgT Sanglier, D Milea, D Saragoussi, et al.
Pageof 11